To the best of our knowledge, this is the first study to report SLC25A38 protein expression in ALL and preliminarily identify that a high expression of SLC25A38 is a common phenomenon in ALL, with certain clinical significance. Here, SLC25A38 is linked to acute lymphoblastic leukemia.